Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-72.18	6.57	23.63
Graham Fair Price	41.42	1.21	0.86
PEG	-61.65	0.02	-0.06
Price/Book	8.51	0.41	0.38
Price/Cash Flow	-40.79	0.86	1.45
Prices/Earnings	-45.74	2.41	4.45
Price/Sales	-45.74	0.10	0.18
Price/FCF	-40.79	0.86	1.45
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-7.57	0.05	0.06
Operating Margin	1.60	0.02	0.02
ROA	100.00	< 0.005	< 0.005
ROE	0.02	0.04	100.00
ROIC	0.02	0.05	154.80
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.36	-0.17	-108.03
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.62	1.03	66.37
EPS QOQ	-0.71	1.00	41.46
FCF QOQ	1.36	0.83	-38.96
Revenue QOQ	-0.54	1.00	85.67
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	< 0.005	< 0.005	-50.24
Days Sales Outstanding (DSO)	233.36	118.53	-49.21
Inventory Turnover	1228988000.00	2469752000.00	100.96
Debt/Capitalization	0.53	0.41	-22.28
Quick Ratio	1.06	1.08	1.48
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	1.24	1.24	0.00
Cash	0.47	0.47	0.00
Capex	< 0.005	< 0.005	-105.47
Free Cash Flow	0.32	0.59	83.27
Revenue	2.61	5.23	100.00
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.11	1.11	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	15.75	3.03	-80.79
Naive Interpretation	Member

06 - Financial Health · Bad

Rating